Atai Life Sciences N.V. (ATAI) Presents at H.C.

Group 1 - The core focus of atai Life Sciences is on developing effective mental health treatments, particularly through short-duration psychedelics [1] - The company aims to transform patient outcomes by providing commercially scalable interventional psychiatry therapies that can be integrated into healthcare systems [1] - The presentation took place at H.C. Wainwright's 27th Annual Global Investment Conference, highlighting the significance of the event for investors and stakeholders [1][2]